AngioDynamics announces plans to consolidate facilities in its New York home base, including layoffs for up to 100 workers.
AngioDynamics (NSDQ:ANGO) said it plans to lay off up to 100 workers, or about 7.5% of its workforce, as it consolidates its footprint in upstate New York.
Harvard Bioscience announces mass layoffs estimated to save about $2 million per year starting in 2014.
Massachusetts medtech company Harvard Bioscience's (NSDQ:HBIO) announced today that it plans to cut about 13% of its global workforce, expecting to reap about $2 million in annual savings.
Johnson & Johnson officials reveal to MassDevice.com plans to restructure its diabetes division to "get in front" of pricing and reimbursement pressures, saying an unspecified number of layoffs will occur.
Johnson & Johnson (NYSE:JNJ) told MassDevice.com today that it plans to make an unspecified number of job cuts, consolidate facilities and change the reporting structure on some of the sales units within its diabetes unit to "get in front" of pricing and reimbursement pressures.
Solta Medical says it plans to lay of 40 workers, or 9% of its total workforce, and shutter a plant in Louisville, Colo.
Solta Medical (NSDQ:SLTM) yesterday detailed its new cost-cutting measures, saying it plans to lay off 40 workers, or roughly 9% of its total workforce "across all areas of the company."
Solta Medical shares are up after the medical device company swings to 3rd-quarter black ink and says it's considering 'strategic options,' including a possible sale, and inaugurates a plan to cut costs by lowering its head count.
Solta Medical (NSDQ:SLTM) shares gained today after the medical device company reported a swing to 3rd-quarter black ink and said it's considering a sale.
Acquisitions prompt C.R. Bard to add jobs at its Queensbury, N.Y., plant after 2 rounds of layoffs last year.
C.R. Bard (NYSE:BCR) began adding jobs in its Queensbury, N.Y., facility, adding 30-40 positions after 2 rounds of layoffs last year.
Boston Scientific announces the departure of long-time CFO Jeff Capello as it gears up to lay off up to 1,500 workers amid strong 3rd-quarter results.
Boston Scientific (NYSE:BSX) dropped a couple of bombshells along with its 3rd-quarter earnings, saying it plans to lay off up to 1,500 workers by the end of 2015 and that long-time CFO Jeff Capello plans to step down at the end of the year.